QQQ   357.47 (-0.15%)
AAPL   170.56 (-0.08%)
MSFT   315.75 (+0.67%)
META   300.61 (-1.10%)
GOOGL   130.70 (-1.22%)
AMZN   126.93 (+0.75%)
TSLA   247.04 (+0.27%)
NVDA   433.94 (+0.71%)
NIO   8.94 (+0.34%)
BABA   86.72 (+1.38%)
AMD   103.05 (+0.28%)
T   14.97 (-0.27%)
F   12.36 (-1.59%)
MU   67.86 (+4.08%)
CGC   0.78 (-3.69%)
GE   110.10 (-1.99%)
DIS   80.51 (+0.47%)
AMC   7.92 (+1.67%)
PFE   33.17 (+3.37%)
PYPL   58.25 (+0.12%)
NFLX   375.99 (-0.10%)
QQQ   357.47 (-0.15%)
AAPL   170.56 (-0.08%)
MSFT   315.75 (+0.67%)
META   300.61 (-1.10%)
GOOGL   130.70 (-1.22%)
AMZN   126.93 (+0.75%)
TSLA   247.04 (+0.27%)
NVDA   433.94 (+0.71%)
NIO   8.94 (+0.34%)
BABA   86.72 (+1.38%)
AMD   103.05 (+0.28%)
T   14.97 (-0.27%)
F   12.36 (-1.59%)
MU   67.86 (+4.08%)
CGC   0.78 (-3.69%)
GE   110.10 (-1.99%)
DIS   80.51 (+0.47%)
AMC   7.92 (+1.67%)
PFE   33.17 (+3.37%)
PYPL   58.25 (+0.12%)
NFLX   375.99 (-0.10%)
QQQ   357.47 (-0.15%)
AAPL   170.56 (-0.08%)
MSFT   315.75 (+0.67%)
META   300.61 (-1.10%)
GOOGL   130.70 (-1.22%)
AMZN   126.93 (+0.75%)
TSLA   247.04 (+0.27%)
NVDA   433.94 (+0.71%)
NIO   8.94 (+0.34%)
BABA   86.72 (+1.38%)
AMD   103.05 (+0.28%)
T   14.97 (-0.27%)
F   12.36 (-1.59%)
MU   67.86 (+4.08%)
CGC   0.78 (-3.69%)
GE   110.10 (-1.99%)
DIS   80.51 (+0.47%)
AMC   7.92 (+1.67%)
PFE   33.17 (+3.37%)
PYPL   58.25 (+0.12%)
NFLX   375.99 (-0.10%)
QQQ   357.47 (-0.15%)
AAPL   170.56 (-0.08%)
MSFT   315.75 (+0.67%)
META   300.61 (-1.10%)
GOOGL   130.70 (-1.22%)
AMZN   126.93 (+0.75%)
TSLA   247.04 (+0.27%)
NVDA   433.94 (+0.71%)
NIO   8.94 (+0.34%)
BABA   86.72 (+1.38%)
AMD   103.05 (+0.28%)
T   14.97 (-0.27%)
F   12.36 (-1.59%)
MU   67.86 (+4.08%)
CGC   0.78 (-3.69%)
GE   110.10 (-1.99%)
DIS   80.51 (+0.47%)
AMC   7.92 (+1.67%)
PFE   33.17 (+3.37%)
PYPL   58.25 (+0.12%)
NFLX   375.99 (-0.10%)
Positive News SentimentPositive News
NASDAQ:VINC

Vincerx Pharma (VINC) Earnings Date, Estimates & Call Transcripts

$1.02
-0.02 (-1.92%)
(As of 01:48 PM ET)
Compare
Today's Range
$0.98
▼
$1.09
50-Day Range
$0.66
▼
$1.29
52-Week Range
$0.63
▼
$1.95
Volume
159,820 shs
Average Volume
93,067 shs
Market Capitalization
$21.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Nov. 9Estimated
Actual EPS
(Aug. 7)
-$0.52 Beat By $0.13
Consensus EPS
(Aug. 7)
-$0.65
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

VINC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VINC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vincerx Pharma Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.69)($0.69)($0.69)
Q2 20231($0.64)($0.64)($0.64)
Q3 20232($0.49)($0.32)($0.41)
Q4 20232($0.43)($0.30)($0.37)
FY 20236($2.25)($1.95)($2.10)

VINC Earnings Date and Information

Vincerx Pharma last announced its earnings results on August 7th, 2023. The reported ($0.52) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.65) by $0.13. Vincerx Pharma has generated ($2.65) earnings per share over the last year (($2.65) diluted earnings per share). Earnings for Vincerx Pharma are expected to grow in the coming year, from ($1.85) to ($0.44) per share. Vincerx Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off prior year's report dates.

Vincerx Pharma Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2023
Estimated)		------- 
8/7/2023Q2 2023($0.65)($0.52)+$0.13($0.52)--
5/11/2023Q1 2023($0.69)($0.68)+$0.01($0.68)--
3/28/2023Q4 2022($0.63)($0.65)($0.02)($0.65)--
11/10/2022Q3 2022($0.80)($0.80)-($0.80)--
8/11/2022Q2 2022($0.92)($0.88)+$0.04($0.88)--
5/12/2022Q1 2022($0.87)($0.79)+$0.08($0.79)--
3/29/2022Q4 2021($0.93)($0.85)+$0.08($1.39)--
11/12/2021Q3 2021($0.79)($1.02)($0.23)($0.65)--
8/12/2021Q2 2021($0.30)($0.12)+$0.18($0.12)--
5/16/2021Q1 2021($0.32)($0.46)($0.14)($0.46)--












Vincerx Pharma Earnings - Frequently Asked Questions

When is Vincerx Pharma's earnings date?

Vincerx Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 9th, 2023 based off last year's report dates. Learn more on VINC's earnings history.

Did Vincerx Pharma beat their earnings estimates last quarter?

In the previous quarter, Vincerx Pharma (NASDAQ:VINC) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.65) by $0.13. Learn more on analysts' earnings estimate vs. VINC's actual earnings.

How much profit does Vincerx Pharma generate each year?

Vincerx Pharma (NASDAQ:VINC) has a recorded net income of -$65.37 million. VINC has generated -$2.65 earnings per share over the last four quarters.

What is Vincerx Pharma's EPS forecast for next year?

Vincerx Pharma's earnings are expected to grow from ($1.85) per share to ($0.44) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:VINC) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -